These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 37846885)
1. Monoaminergic Degeneration and Ocular Motor Abnormalities in De Novo Parkinson's Disease. Woo KA; Joun JH; Yoon EJ; Lee CY; Jeon B; Kim YK; Lee JY Mov Disord; 2023 Dec; 38(12):2291-2301. PubMed ID: 37846885 [TBL] [Abstract][Full Text] [Related]
2. The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's disease. Maillet A; Krack P; Lhommée E; Météreau E; Klinger H; Favre E; Le Bars D; Schmitt E; Bichon A; Pelissier P; Fraix V; Castrioto A; Sgambato-Faure V; Broussolle E; Tremblay L; Thobois S Brain; 2016 Sep; 139(Pt 9):2486-502. PubMed ID: 27538418 [TBL] [Abstract][Full Text] [Related]
3. 18F-FP-CIT Positron Emission Tomography for Correlating Motor and Cognitive Symptoms of Parkinson's Disease. Yang Y; Cheon M; Kwak YT Dement Neurocogn Disord; 2017 Sep; 16(3):57-63. PubMed ID: 30906372 [TBL] [Abstract][Full Text] [Related]
4. Correlation of Parkinson disease severity and 18F-DTBZ positron emission tomography. Hsiao IT; Weng YH; Hsieh CJ; Lin WY; Wey SP; Kung MP; Yen TC; Lu CS; Lin KJ JAMA Neurol; 2014 Jun; 71(6):758-66. PubMed ID: 24756323 [TBL] [Abstract][Full Text] [Related]
6. White Matter Hyperintensities, Dopamine Loss, and Motor Deficits in De Novo Parkinson's Disease. Jeong SH; Lee HS; Jung JH; Baik K; Lee YH; Yoo HS; Sohn YH; Chung SJ; Lee PH Mov Disord; 2021 Jun; 36(6):1411-1419. PubMed ID: 33513293 [TBL] [Abstract][Full Text] [Related]
7. Patterns of grey matter loss associated with motor subscores in early Parkinson's disease. Li X; Xing Y; Martin-Bastida A; Piccini P; Auer DP Neuroimage Clin; 2018; 17():498-504. PubMed ID: 29201638 [TBL] [Abstract][Full Text] [Related]
8. Characteristics and influencing factors of Kangli F; Hongguang Z; Yinghua L; Xiaoxiao D; Yuyin D; Lulu G; Yi L; Zhihui S; Ying Z Front Neurol; 2023; 14():1195577. PubMed ID: 37483437 [TBL] [Abstract][Full Text] [Related]
9. In vivo detection of monoaminergic degeneration in early Parkinson disease by (18)F-9-fluoropropyl-(+)-dihydrotetrabenzazine PET. Lin SC; Lin KJ; Hsiao IT; Hsieh CJ; Lin WY; Lu CS; Wey SP; Yen TC; Kung MP; Weng YH J Nucl Med; 2014 Jan; 55(1):73-9. PubMed ID: 24287322 [TBL] [Abstract][Full Text] [Related]
10. An FP-CIT PET comparison of the difference in dopaminergic neuronal loss in subtypes of early Parkinson's disease. Song IU; Chung YA; Oh JK; Chung SW Acta Radiol; 2014 Apr; 55(3):366-71. PubMed ID: 23943629 [TBL] [Abstract][Full Text] [Related]
11. Magnetic Susceptibility Associates With Dopaminergic Deficits and Cognition in Parkinson's Disease. Uchida Y; Kan H; Sakurai K; Inui S; Kobayashi S; Akagawa Y; Shibuya K; Ueki Y; Matsukawa N Mov Disord; 2020 Aug; 35(8):1396-1405. PubMed ID: 32369660 [TBL] [Abstract][Full Text] [Related]
12. Correlating Parkinson's disease motor symptoms with three-dimensional [(18)F]FP-CIT PET. Chung M; Park YS; Kim JS; Kim YJ; Ma HI; Jang SJ; Huh R; Kim HS; Kim WC Jpn J Radiol; 2015 Oct; 33(10):609-18. PubMed ID: 25952404 [TBL] [Abstract][Full Text] [Related]
13. Striatal dopamine transporter uptake, parkinsonism and cognition in Alzheimer's disease. Kang S; Jeon S; Lee YG; Ye BS Eur J Neurol; 2023 Oct; 30(10):3105-3113. PubMed ID: 37493955 [TBL] [Abstract][Full Text] [Related]
14. Striatal dopamine loss and discriminative sensory dysfunction in Parkinson's disease. Lyoo CH; Ryu YH; Lee MJ; Lee MS Acta Neurol Scand; 2012 Nov; 126(5):344-9. PubMed ID: 22380639 [TBL] [Abstract][Full Text] [Related]
15. Dopaminergic and Serotonergic Degeneration and Cortical [ Orso B; Arnaldi D; Girtler N; Brugnolo A; Doglione E; Mattioli P; Biassoni E; Fancellu R; Massa F; Bauckneht M; Chiola S; Morbelli S; Nobili F; Pardini M Mov Disord; 2021 Oct; 36(10):2293-2302. PubMed ID: 34021923 [TBL] [Abstract][Full Text] [Related]
16. Impaired finger dexterity and nigrostriatal dopamine loss in Parkinson's disease. Lee SH; Lee MJ; Lyoo CH; Cho H; Lee MS J Neural Transm (Vienna); 2018 Sep; 125(9):1333-1339. PubMed ID: 29971496 [TBL] [Abstract][Full Text] [Related]
17. SPECT imaging of the dopamine transporter with [(123)I]-beta-CIT reveals marked decline of nigrostriatal dopaminergic function in Parkinson's disease with urinary dysfunction. Sakakibara R; Shinotoh H; Uchiyama T; Yoshiyama M; Hattori T; Yamanishi T J Neurol Sci; 2001 Jun; 187(1-2):55-9. PubMed ID: 11440745 [TBL] [Abstract][Full Text] [Related]
18. The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson's disease. Broussolle E; Dentresangle C; Landais P; Garcia-Larrea L; Pollak P; Croisile B; Hibert O; Bonnefoi F; Galy G; Froment JC; Comar D J Neurol Sci; 1999 Jul; 166(2):141-51. PubMed ID: 10475108 [TBL] [Abstract][Full Text] [Related]
19. [ Stark AJ; Smith CT; Petersen KJ; Trujillo P; van Wouwe NC; Donahue MJ; Kessler RM; Deutch AY; Zald DH; Claassen DO Neuroimage Clin; 2018; 18():433-442. PubMed ID: 29541577 [TBL] [Abstract][Full Text] [Related]
20. SPECT measurement of iodine-123-beta-CIT binding to dopamine and serotonin transporters in Parkinson's disease: correlation with symptom severity. Kim SE; Lee WY; Choe YS; Kim JH Neurol Res; 1999 Apr; 21(3):255-61. PubMed ID: 10319333 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]